NanoVibronix, Inc. filed an 8-K on December 4, 2025, reporting that directors Christopher Fashek, Thomas Mika, Martin Goldstein, M.D., and Brian Murphy retired from the Board effective immediately, citing personal reasons. The company also approved an increase of 1,200,000 shares available under its 2024 Long-Term Incentive Plan during its Annual Meeting held on the same date.